Ethyl Pyruvate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameEthyl Pyruvate
Drug Alias NameCTI-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid peroxidation inhibitorsFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsCoronary DiseaseHeart Valve Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCritical Therapeutics
Active IndicationsN/A
Inactive IndicationsCoronary DiseaseHeart Valve Diseases

Other Information

ATC CodeN/A
Related LinksN/A